Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Ubatec, explained in plain language.
This study is for transgender women with HIV who are already on a stable three-drug regimen. It tests switching to a simpler two-drug combination (dolutegravir plus lamivudine) to see if it keeps the virus under control. About 50 participants will take the two-drug pill for 48 we…
Phase: PHASE4 • Sponsor: UBATEC • Aim: Disease control
Last updated May 26, 2026 03:43 UTC